Zobrazeno 1 - 10
of 5 464
pro vyhledávání: '"vaccinia virus (VACV)"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Virology 2011 419(2):97-106
Autor:
Kilinc, Mehmet Okyay1,2, Ehrig, Klaas1, Pessian, Maysam2, Minev, Boris R.2,3, Szalay, Aladar A.1,2,3 aladar.szalay@virchow.uni-wuerzburg.de
Publikováno v:
Journal of Translational Medicine. 12/20/2016, Vol. 14, p1-12. 12p.
Autor:
Alba Grifoni, Yun Zhang, Alison Tarke, John Sidney, Paul Rubiro, Maria Reina-Campos, Gilberto Filaci, Jennifer Dan, Richard H. Scheuermann, Alessandro Sette
The current Monkeypox virus (MPXV) outbreak in non-endemic countries is raising concern about the pandemic potential of novel orthopoxviruses. Little is known regarding MPXV immunity in the context of MPXV infection or vaccination with Vaccinia-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f231552f18cdee29af7bb3c1cbbffd35
https://doi.org/10.1101/2022.09.06.506534
https://doi.org/10.1101/2022.09.06.506534
Autor:
Eric A. Weaver, Zhigang Wang, Brianna L. Bullard, Clinton Jones, Amber B Rico, Annabel T Olson, Alexandria C Linville, Matthew S. Wiebe
Publikováno v:
Journal of Virology. 93
Comparative examination of viral and host protein homologs reveals novel mechanisms governing downstream signaling effectors of both cellular and viral origin. The vaccinia virus B1 protein kinase is involved in promoting multiple facets of the virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ce61cd7e4197986a2ff32a414d2dd3
https://doi.org/10.1128/jvi.00855-19
https://doi.org/10.1128/jvi.00855-19
Autor:
Howell, Liam Michael1 (AUTHOR), Gracie, Nicholas Peter1 (AUTHOR), Newsome, Timothy Peter1,2 (AUTHOR) tim.newsome@sydney.edu.au
Publikováno v:
PLoS Pathogens. 8/2/2024, Vol. 20 Issue 8, p1-24. 24p.
Publikováno v:
Virology. 419(2):97-106
To test the potential for parainfluenza virus 5 (PIV5)-based vectors to provide protection from vaccinia virus (VACV) infection, PIV5 was engineered to express secreted VACV L1R and B5R proteins, two important antigens for neutralization of intracell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c3962328d7c9ac8b9eb6255a701c0f
Autor:
Jack T. Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A. Tamming, Giuseppe Pugliese, Nikolas T. Martin, Mathieu J. F. Crupi, Julia Petryk, Bradley Austin, Xiaohong He, Ricardo Marius, Jessie Duong, Carter Jones, Emily E. F. Fekete, Nouf Alluqmani, Andrew Chen, Stephen Boulton, Michael S. Huh, Matt Y. Tang, Zaid Taha, Elena Scut, Jean-Simon Diallo, Taha Azad, Brian D. Lichty, Carolina S. Ilkow, John C. Bell
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Poxvirus vectors represent versatile modalities for engineering novel vaccines and cancer immunotherapies. In addition to their oncolytic capacity and immunogenic influence, they can be readily engineered to express multiple large transgenes. However
Externí odkaz:
https://doaj.org/article/f7cfd3f77d384dec8678da5baade9481
Autor:
Vladimir A. Gushchin, Darya A. Ogarkova, Inna V. Dolzhikova, Olga V. Zubkova, Igor V. Grigoriev, Andrei A. Pochtovyi, Anna A. Iliukhina, Tatiana A. Ozharovskaia, Nadezhda A. Kuznetsova, Daria D. Kustova, Artem Y. Shelkov, Denis I. Zrelkin, Alina S. Odintsova, Daria M. Grousova, Vladislav Y. Kan, Sona A. Davtyan, Andrei E. Siniavin, Elizaveta D. Belyaeva, Andrei G. Botikov, Arina A. Bessonova, Lyudmila A. Vasilchenko, Daria V. Vasina, Denis A. Kleymenov, Egor A. Slutskiy, Artem P. Tkachuk, Olga A. Burgasova, Svetlana Y. Loginova, Evgeny V. Rozhdestvensky, Dmitry V. Shcheblyakov, Alexander N. Tsibin, Andrey G. Komarov, Vladimir I. Zlobin, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that
Externí odkaz:
https://doaj.org/article/84ad75d454a44bc8b7f615c5d10c8ed5
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 731-738 (2020)
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (
Externí odkaz:
https://doaj.org/article/20564782805d4bf389b34a810fa140b0